H.R. 124 explained · 119th Congress · Pending in Congress
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Cosponsors: none · per Congress.gov, 2026-10-12
Introduced: 2025-01-03
Latest action (2025-01-03): Referred to the House Committee on Energy and Commerce.
What H.R. 124 does, in plain terms
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Official summary by the Congressional Research Service, via Congress.gov.
Constitution Index
“VFA Constitution grade”
Not graded yet
H.R. 124 has not been graded yet. New measures with an official summary are graded daily under the published rubric.
What should pass
“VFA SI Solution”
No solution yet
A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.
For journalists and bloggers
“Embed this grade”
Free to use with the link back. The badge and card update when the grade changes. Embed terms →
